GGrantIndex
Sort

46,585 grants matching heart failure

Automated clinic blood pressure assessment and detection of white coat and masked hypertension study in African Americans

$792,860
Marwah Abdalla · Columbia University Health Sciences · R01 · FY2020 · HL

MTSS1 in Myocardial Disease

$792,858
Thomas P Cappola · University Of Pennsylvania · R01 · FY2022 · HL

Vitamin B12 status, cognitive decline and incident dementia

$792,825
Paul F Jacques · Tufts University Boston · R01 · FY2019 · AG

Role of Mitochondrial Health in Acute and Chronic Kidney Disease in Older Adults

$792,748
Michael G Shlipak · Northern California Institute/Res/Edu · R01 · FY2018 · AG

Cardiac MR to Improve Clinical Risk Prediction in Defibrilator Patients

$792,704
Gordon Frank Tomaselli · Johns Hopkins University · R01 · FY2017 · HL

RCT of automated hovering for congestive heart failure management

$792,690
Kevin G Volpp · University Of Pennsylvania · R01 · FY2015 · HL

FHFs and Cardiac Electrophysiology

$792,661
Glenn I Fishman · New York University School Of Medicine · R01 · FY2019 · HL

Urocortin-2 Gene Transfer for Type 1 Diabetes and Associated LV Dysfunction

$792,556
H. Kirk Hammond · Renova Therapeutics, Inc. · R42 · FY2023 · HL

Effects of a Pulse Induced by a Constant-Flow Total Cardiac Replacement Device

$792,506
O. H. Frazier · Texas Heart Institute · R01 · FY2010 · HL

Handoffs and Transitions in Critical Care - Understanding Scalability

$792,455
Meghan Brooks Lane-Fall · University Of Pennsylvania · R01 · FY2020 · HL

Carotid Intraplaque Hemorrhage: MRI of Therapeutic Response and Clinical Sequelae

$792,401
Chun Yuan · University Of Washington · R01 · FY2014 · HL

Portable electrical nitric oxide generator for treatment of pulmonary hypertension accompanying interstitial lung disease

$792,305
Greg Hall · Third Pole, Inc. · R44 · FY2022 · TR

Cardiovascular Risk, Vascular and Kidney Damage in COVID-19 Survivors

$792,262
Julio Alonso Chirinos Medina · University Of Pennsylvania · R01 · FY2023 · HL

Elucidating the structural insights into the BMP receptor mutations in PAH

$792,256
Akiko Hata · University Of California, San Francisco · R01 · FY2025 · HL

Observational Study of Delay in Heart Failure

$792,191
Robert Joel Goldberg · Univ Of Massachusetts Med Sch Worcester · R01 · FY2009 · HL

MRI Phenotyping of Severe BPD and Prediction of Outcomes

$792,032
Jason C Woods · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · HL

Pathophysiology of Myocardial Disease

$791,940
David Alan Kass · Johns Hopkins University · T32 · FY2013 · HL

Cardiovascular Cell Therapy Research Network

$791,909
James T. Willerson · Texas Heart Institute · UM1 · FY2014 · HL

Phone Calls to Promote Adherence with Inhaled Corticoste

$791,809
William M Vollmer · Kaiser Foundation Research Institute · R01 · FY2006 · HL

MR-compatible Devices for the Diagnosis and Treatment of Cardiomyopathies

$791,786
Dara L Kraitchman · Johns Hopkins University · R01 · FY2021 · HL

Optimized Mitral Annuloplasty

$791,755
Robert C Gorman · University Of Pennsylvania · R01 · FY2019 · HL

MAESTRO-PAF for Major Adverse Events and Stroke in Paroxysmal Atrial Fibrillation

$791,567
Eliseo Guallar · Johns Hopkins University · R01 · FY2017 · HL

New infusible ECM hydrogel for treating acute myocardial infarction

$791,543
Adam M Kinsey · Ventrix, Inc. · R43 · FY2020 · HL

The Impact of Bundled Payments for Cardiopulmonary Disease on High-Risk Populations

$791,495
Karen Ellen Joynt Maddox · Washington University · R01 · FY2020 · HL

Treatment of post-infarction cardiac remodeling using image-guided delivery of microRNA-loaded microbubbles and ultrasound-mediated cavitation

$791,485
Flordeliza S Villanueva · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL